In HF patients with refractory AF undergoing atrioventricular node ablation, CSP with left bundle branch area pacing was non-inferior to BVP for LVEF improvement at 6 months, providing comparable clinical outcomes and a favourable procedural profile.
Abstract
Background
AND
Aims
Randomized evidence comparing conduction system pacing (CSP) and biventricular pacing (BVP) following atrioventricular node ablation in patients with refractory atrial fibrillation (AF) and heart failure (HF) remains limited. This study evaluated whether CSP with left bundle branch area pacing is non-inferior to BVP in patients undergoing atrioventricular node ablation.
Methods
CONDUCT-AF was an investigator-initiated, multicentre, randomized trial conducted across 10 European centres. Patients with refractory AF, HF with left ventricular ejection fraction (LVEF) < 50%, narrow QRS duration (≤120 ms), and N-terminal pro-B-type natriuretic peptide > 600 ng/L were randomized 1:1 to CSP or BVP. The primary endpoint was the change in LVEF after 6 months, assessed by an independent core laboratory. Secondary endpoints included echocardiographic, clinical, and procedural outcomes. Analyses followed the intention-to-treat principle.
Results
Eighty-two patients were randomized (mean age 72 ± 7 years, 46% male). At 6 months, LVEF improved similarly in CSP {from 36% [95% confidence interval (CI) 33-39] to 46% [95% CI 44-49]; P < .001} and BVP group [from 34% (95% CI 31-36) to 46% (95% CI 43-49); P < .001]. The between-group difference was .4% (95% CI -3.1-3.8; P = .002 for non-inferiority). Changes in left ventricular volumes, clinical parameters, and composite endpoint of worsening HF or cardiovascular death were comparable between groups. Paced QRS [mean difference -14 ms (95% CI -19 to -9; P < .001)] and procedural and fluoroscopy times were significantly shorter with CSP compared with BVP.
Conclusions
In HF patients with refractory AF undergoing atrioventricular node ablation, CSP with left bundle branch area pacing was non-inferior to BVP for LVEF improvement at 6 months, providing comparable clinical outcomes and a favourable procedural profile.
BACKGROUND
Conduction system pacing (CSP) has emerged as a promising modality for cardiac resynchronization therapy, but evidence of CSP in heart failure (HF) remains controversial.
OBJECTIVES
The authors aimed to compare the efficacy and safety of CSP, including left bundle branch area pacing (LBBAP) and His bundle...
P. Pajareya, W. Chuanchai, K. Laohasurayotin et al.· JACC: Asia· 0 citations
BACKGROUND AND AIMS
Population aging is increasing atrial fibrillation (AF) prevalence. In elderly patients with persistent AF, pulmonary-vein isolation (PVI) has limited success, but is widely used. Pacemaker-implantation with atrioventricular-node ablation (PM+AVNA) provides effective symptom control, but the relativ...
A. Boehmer, Lars Eckardt, M. Rothe et al.· European Heart Journal· 0 citations
Conventional right ventricular pacing (RVP) is associated with an increased risk of pacing-induced cardiomyopathy, heart failure (HF), and atrial fibrillation. While conduction system pacing (CSP) - comprising His-bundle and left bundle branch area pacing (LBBAP) - has emerged as a promising physiological alterna...
M. Bistriceanu, C. Ursu, A. Deaconu et al.· European Heart Journal· 0 citations
Left bundle branch area pacing (LBBAP) with atrioventricular node (AVN) ablation has emerged as a promising therapy for patients with atrial fibrillation (AF) and symptomatic heart failure (HF). However, it remains unclear which patients are likely responders and which may derive limited benefit.
This stud...
Li-Shui Shen, H. Li, K. Tang et al.· European Heart Journal· 0 citations
Conduction system pacing has emerged as a novel alternative to conventional biventricular pacing in patients with heart failure requiring cardiac resynchronization therapy (CRT).
The aim of this study was to evaluate the rate of response and the degree of ventricular dyssynchrony in patients undergoing CRT...
J. Mizner, T. Knize, L. Povišer et al.· European Heart Journal· 0 citations